Clinical Trial Categories
Solid Tumors Trials
STAR 20245
Avavilable at 1 location
CRESTONE: A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors (ELVCAP-001-01)
STAR 18164
Avavilable at 1 location
A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors (BLU-667-1101)
STAR 19092
Avavilable at 1 location
A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)
BLU-667-1101
Avavilable at 1 location
A Phase 1/2 Study of the Highly Selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, NSCLC, and Other Advanced Solid Tumors
STAR 19151
Avavilable at 2 locations
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)
BO41932
Avavilable at 13 locations
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
BO41932
Avavilable at 13 locations
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
BO41932
Avavilable at 13 locations
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
BO41932
Avavilable at 13 locations
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
BO41932
Avavilable at 13 locations
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
